Dihexa vs Semax
Research Verdict
Semax is the stronger research reference for the stated comparison criteria. Semax: Russian multicenter RCT data in ischemic stroke (Lebedeva 2008, n=60), approved in Russia and Ukraine.
Quick Answers
Which is better, Dihexa or Semax?
Semax is the stronger research reference for the stated comparison criteria. Semax: Russian multicenter RCT data in ischemic stroke (Lebedeva 2008, n=60), approved in Russia and Ukraine.
What is the key difference between Dihexa and Semax?
Semax acts via BDNF upregulation and neuroprotection; dihexa acts via HGF/Met receptor potentiation - different mechanisms with different safety profiles. Semax has the superior safety characterization in humans.
Evidence Comparison
Semax: Russian multicenter RCT data in ischemic stroke (Lebedeva 2008, n=60), approved in Russia and Ukraine. Dihexa: zero human data, single lab, proto-oncogenic HGF/Met mechanism. Semax substantially outperforms dihexa on any evidence quality metric.
Evidence Context Favoring Dihexa
Basic research into HGF/Met-mediated synaptogenesis - for mechanistic understanding, not therapeutic intent.
Evidence Context Favoring Semax
Cognitive enhancement or neuroprotection research requiring any human evidence; semax is the research-supported choice in this pairing.
Side-by-Side Snapshot
| Evidence grade | Dihexa: Level D Semax: Level C |
|---|---|
| Research status | Dihexa: Preclinical Semax: Approved Outside US |
| Primary category | Dihexa: Cognitive & Nootropic Semax: Cognitive & Nootropic |
| Cited studies | Dihexa: 2 Semax: 2 |